{
    "clinical_study": {
        "@rank": "116044", 
        "brief_summary": {
            "textblock": "-  Vascular Inflammation is a key factor in both the pathogenesis and outcome of\n           atherosclerosis. 18FDG-PET is a promising novel tool for identifying and quantifying\n           vascular inflammation within atherosclerotic plaque\n\n        -  Recently, unique subsets of obese individuals, such as metabolically obese but normal\n           weight (MONW) and metabolically healthy obese (MHO), have been getting an attention\n\n        -  Therefore, the purpose of this study is to examine the relationship of vascular\n           inflammation,measured by FDG-PET, with various body sized phenotypes"
        }, 
        "brief_title": "Vascular Inflammation Stratified by Body Size Phenotype", 
        "condition": [
            "Atherosclerosis", 
            "Obesity", 
            "Metabolic Syndrome"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Obesity", 
                "Metabolic Syndrome X"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy patients for visiting routine medical check in our clinic\n\n        Exclusion Criteria:\n\n          -  history of CVD (myocardial infarction, unstable angina, stroke, or cardiovascular\n             revascularization)\n\n          -  stage 2 hypertension (resting blood pressure, \u2265160/100 mmHg)\n\n          -  history of inflammatory conditions that affect the study results\n\n          -  taking medications that might affect inflammatory status, including steroid and\n             non-steroidal anti-inflammatory drug within 6 months\n\n          -  or malignancy or severe renal or hepatic disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Healthy volunteers who underwent a medical health check in the health promotion center in\n        Korea University Guro Hospital"
            }
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01979068", 
            "org_study_id": "PET_MONW"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Korea University Guro Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "max TBR values stratified by the four body size phenotypes", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01979068"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korea University", 
            "investigator_full_name": "K. M. Choi", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Framingham risk scores according to the four body size phenotypes", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "source": "Korea University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Korea University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2008", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}